These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21285184)

  • 41. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Callegari PE; Schaible TF; Boscia JA
    JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
    [No Abstract]   [Full Text] [Related]  

  • 42. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Hochman D; Wolff B
    JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
    [No Abstract]   [Full Text] [Related]  

  • 43. Adalimumab-induced lupus erythematosus.
    Al-Niaimi F
    Eur J Dermatol; 2009; 19(4):380. PubMed ID: 19451046
    [No Abstract]   [Full Text] [Related]  

  • 44. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

  • 45. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
    Nagashima T; Minota S
    J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
    [No Abstract]   [Full Text] [Related]  

  • 46. [Comparative efficacy of infliximab and adalimumab in patients with rheumatoid arthritis].
    Tiurin VP; Mezenova TV; Iutrina TO; Usacheva IuV
    Klin Med (Mosk); 2013; 91(7):55-60. PubMed ID: 24437172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug-induced lupus erythematosus in a patient treated with adalumimab.
    Spillane AP; Xia Y; Sniezek PJ
    J Am Acad Dermatol; 2007 May; 56(5 Suppl):S114-6. PubMed ID: 17434034
    [No Abstract]   [Full Text] [Related]  

  • 48. Unstable diabetes in a patient receiving anti-TNF-alpha for rheumatoid arthritis.
    Boulton JG; Bourne JT
    Rheumatology (Oxford); 2007 Jan; 46(1):178-9. PubMed ID: 16998233
    [No Abstract]   [Full Text] [Related]  

  • 49. Systemic listeriosis with adalimumab therapy.
    Murphy G; Schmidt-Martin D; Hynes BG; Harney S
    J Clin Rheumatol; 2009 Oct; 15(7):369-70. PubMed ID: 20009978
    [No Abstract]   [Full Text] [Related]  

  • 50. Development of varicella during adalimumab therapy.
    Lee DH; Kim HS; Song YW; Cho KH
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):687-8. PubMed ID: 17447988
    [No Abstract]   [Full Text] [Related]  

  • 51. Rapidly progressive malignant melanoma in a patient treated with tocilizumab.
    Bonny M; Buyse V; Suys E
    J Am Acad Dermatol; 2012 Aug; 67(2):e78-9. PubMed ID: 22794823
    [No Abstract]   [Full Text] [Related]  

  • 52. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.
    Kalyoncu U; Karadag O; Akdogan A; Kisacik B; Erman M; Erguven S; Ertenli AI
    Scand J Infect Dis; 2007; 39(5):475-8. PubMed ID: 17464877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New therapies for treatment of rheumatoid arthritis.
    Smolen JS; Aletaha D; Koeller M; Weisman MH; Emery P
    Lancet; 2007 Dec; 370(9602):1861-74. PubMed ID: 17570481
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycobacterium chelonae infection associated with adalimumab therapy.
    Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
    Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
    [No Abstract]   [Full Text] [Related]  

  • 55. Adalimumab-induced bronchospasm: not a class effect.
    Janssen R; Krivokuca I; Kruize AA; Koenderman L; Lammers JW
    Thorax; 2008 May; 63(5):472-3. PubMed ID: 18443165
    [No Abstract]   [Full Text] [Related]  

  • 56. Adalimumab-associated pulmonary fibrosis reply.
    Huggett MT; Armstrong R
    Rheumatology (Oxford); 2007 Aug; 46(8):1379-80; author reply 1379. PubMed ID: 17553912
    [No Abstract]   [Full Text] [Related]  

  • 57. [Rheumatoid polyarthritis: a new treatment].
    Perspect Infirm; 2010; 7(5):46-7. PubMed ID: 21744636
    [No Abstract]   [Full Text] [Related]  

  • 58. Disseminated tuberculosis after anti-TNFalpha treatment.
    Agarwal R; Srinivas R; Gupta D
    Lancet; 2007 Aug; 370(9587):564; author reply 565. PubMed ID: 17707746
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Okada SK; Siegel JN
    JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
    [No Abstract]   [Full Text] [Related]  

  • 60. Disseminated tuberculosis after anti-TNFalpha treatment.
    Iizuka M; Watanabe S
    Lancet; 2007 Aug; 370(9587):564; author reply 565. PubMed ID: 17707747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.